136 related articles for article (PubMed ID: 2779078)
1. [Prospective trends in studies on the role of lipoproteins in human atherogenesis: their effect on disease progression, diagnostic value and the possibility of corrective interventions].
Perova NV
Kardiologiia; 1989 Jun; 29(6):5-9. PubMed ID: 2779078
[No Abstract] [Full Text] [Related]
2. [Current approaches to the diagnosis and correction of atherogenic dyslipoproteinemia].
Oganov RG; Perova NV
Kardiologiia; 1989 Oct; 29(10):15-22. PubMed ID: 2615152
[No Abstract] [Full Text] [Related]
3. [Arteriosclerosis. IV. Treatment of dyslipoproteinemia].
Cybulska B; Kłosiewicz-Latoszek L
Wiad Lek; 1985 Sep; 38(17):1251-7. PubMed ID: 4090499
[No Abstract] [Full Text] [Related]
4. [Detection and treatment of lipid disorders].
Barraquer Bordas L
Rev Clin Esp; 1988 Nov; 183(8):427-32. PubMed ID: 3222513
[No Abstract] [Full Text] [Related]
5. The hyperlipoproteinemias.
Patsch W; Patsch JR; Gotto AM
Med Clin North Am; 1989 Jul; 73(4):859-93. PubMed ID: 2657266
[TBL] [Abstract][Full Text] [Related]
6. Lp(a): a link between thrombosis and atherosclerosis.
Scanu AM
Eur J Epidemiol; 1992 May; 8 Suppl 1():76-8. PubMed ID: 1387094
[TBL] [Abstract][Full Text] [Related]
7. [Lipoproteins and their metabolism].
Rywik S; Broda G
Kardiol Pol; 1992; 36(2):110-4. PubMed ID: 1583826
[No Abstract] [Full Text] [Related]
8. [Effect of dietary fats and cholesterol on lipoprotein metabolism].
Cybulska B; Szostak WB
Przegl Lek; 1989; 46(7):615-8. PubMed ID: 2587791
[No Abstract] [Full Text] [Related]
9. [Characteristics of the indicators of the lipoprotein spectrum of blood and the main risk factors of the development of arteriosclerosis among university students in different regions of the USSR].
Olfer'ev AM; Shamarin VM; Petrosian KIu; Koval' SN; Konobeevskaia IN; Aripov BS; Zadoia NA; Nazarenko IL; Kanskaia NV; Kulikov SM
Sov Med; 1991; (9):46-9. PubMed ID: 1839195
[No Abstract] [Full Text] [Related]
10. Lipoprotein Lp(a): impact on atherosclerosis and immunochemical quantification.
Kostner GM
Przegl Lek; 1989; 46(7):560-2. PubMed ID: 2531445
[No Abstract] [Full Text] [Related]
11. [Improved diagnosis of lipoproteins with vasoprotective and vasoaggresive properties].
Mertz DP
Lebensversicher Med; 1979 Nov; 31(6):151-5. PubMed ID: 44336
[No Abstract] [Full Text] [Related]
12. [Dyslipoproteinemia as a coronary risk factor].
Yamamura T
Nihon Rinsho; 2003 Apr; 61 Suppl 4():738-45. PubMed ID: 12735059
[No Abstract] [Full Text] [Related]
13. Lipoprotein metabolism and atherogenesis: implications for therapy.
Kostner GM
Cardiology; 1991; 78(3):194-201. PubMed ID: 1651161
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of dyslipoproteinemia in patients with diabetes mellitus type 2 (non-insulin-dependent)].
Leowski J
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):43-7. PubMed ID: 1409042
[No Abstract] [Full Text] [Related]
15. [Dietary treatment of hyperlipoproteinemia. Reduction of atherogenic lipid fractions in normal subjects].
Weisweiler P
Fortschr Med; 1985 Feb; 103(7):148-50. PubMed ID: 3972329
[No Abstract] [Full Text] [Related]
16. Lipids and proteins of lipoproteins in human atherosclerosis.
Avogaro P; Bittolo-Bon G; Cazzolato G; Belussi F; Pontoglio E
Przegl Lek; 1983; 40(10):713-8. PubMed ID: 6665207
[No Abstract] [Full Text] [Related]
17. [Treatment of hyperlipoproteinemia by plasma exchange].
Homma Y
Nihon Rinsho; 1992 Jan; 50 Suppl():370-3. PubMed ID: 1578709
[No Abstract] [Full Text] [Related]
18. [Dietary fats, lipoproteins and atherogenesis].
Jacotot B
Pathol Biol (Paris); 1985 Apr; 33(4):250-3. PubMed ID: 3892454
[TBL] [Abstract][Full Text] [Related]
19. [The risk and treatment of hyperlipoproteinemias].
Alzamora P; Alegría E; Iglesias I
Rev Med Univ Navarra; 1990; 34(1):29-30, 32-5, 37-40. PubMed ID: 2096448
[TBL] [Abstract][Full Text] [Related]
20. [Dyslipoproteinemia and hyperuricemia in podagra and urinary calculi].
Barats IS
Ter Arkh; 1982; 54(10):52-4. PubMed ID: 7179120
[No Abstract] [Full Text] [Related]
[Next] [New Search]
